SXI Life Sciences
6.306,45
PKT
-366,93
PKT
-5,50
%
Werbung
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 21.04.23 | Roche Sell | Deutsche Bank AG | |
| 18.04.23 | Roche Hold | Jefferies & Company Inc. | |
| 18.04.23 | Novartis Buy | Jefferies & Company Inc. | |
| 17.04.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 12.04.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 11.04.23 | Novartis Underweight | Barclays Capital | |
| 11.04.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 05.04.23 | Roche Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 29.03.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 28.03.23 | Novartis Neutral | UBS AG | |
| 28.03.23 | Novartis Hold | Deutsche Bank AG | |
| 27.03.23 | Roche Equal Weight | Barclays Capital | |
| 27.03.23 | Novartis Buy | Jefferies & Company Inc. | |
| 14.03.23 | Novartis Sell | Deutsche Bank AG | |
| 08.03.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 03.03.23 | Roche Neutral | UBS AG | |
| 27.02.23 | Roche Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 17.02.23 | Novartis Sell | Deutsche Bank AG | |
| 14.02.23 | Roche Sell | Deutsche Bank AG | |
| 13.02.23 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 13.02.23 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 10.02.23 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 09.02.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 07.02.23 | Roche Neutral | UBS AG | |
| 07.02.23 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 07.02.23 | Novartis Sell | Deutsche Bank AG | |
| 06.02.23 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 06.02.23 | Roche Sell | Deutsche Bank AG | |
| 03.02.23 | Roche Outperform | Credit Suisse Group | |
| 03.02.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 03.02.23 | Roche Sell | Deutsche Bank AG | |
| 02.02.23 | Roche Hold | Jefferies & Company Inc. | |
| 02.02.23 | Novartis Underperform | Credit Suisse Group | |
| 02.02.23 | Novartis Sell | Deutsche Bank AG | |
| 02.02.23 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 02.02.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 01.02.23 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 01.02.23 | Novartis Buy | Jefferies & Company Inc. | |
| 01.02.23 | Novartis Neutral | UBS AG | |
| 30.01.23 | Roche Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) |